The clinical potential of recombinant human interleukin 4 and alfa-2b interferon.
Recombinant human interleukin 4 and alfa-2b interferon (Intron A) exhibit multiple biological effects on cells of diverse origin. Interleukin 4 can affect the growth, differentiation and functional activity of lymphoid and myelomonocytic cells. Alfa-2b interferon expresses a broad spectrum of antiviral, immunomodulatory, and antiproliferative activities. These properties suggest a broad clinical application for both cytokines.